Page 21234..1020..»

Category : Nanomedicine

The Promise of Nanomedicine – Laboratory Equipment

More than a decade ago, nanotechnology became an integral part of the overall scientific research world. Governments started funding programs specifically aimed at nanotechnology, research universities opened their facilities and coursework to the new discipline, and journals focusing on nano research became commonplace.And now, many researchers believe, its nanomedicines turn to do the same. Nanomedicinewhich has emerged as nanotechnologys most important sub-disciplineis the application of nanotechnology to the prevention and treatment of disease in the human body. It is already having an impact clinically among some of the deadliest diseases in the world.

Nanomedicine is far from the stuff of science fiction. The possibilities for nanomedicine to help us diagnose, treat and image diseases are endless. Imagine a smart nanomedicine that is able to bind to tumor cells and enhance imaging and diagnosis, at the same time as being able to deliver a gene therapy or chemotherapy agent. With the technologies available to us and our multidisciplinary teams, this will be possible in my lifetime, said Phoebe Phillips, head of the pancreatic cancer translational research group at the University of New South Wales in Sydney.

Phillips and her team have created a nanoparticle that dramatically increases its effectiveness as an anti-cancer drug for patients with pancreatic cancers, which is one of the fastest killing cancers from time of initial detection, often leaving patients with no suitable treatment options and only weeks to live.

While nanomedicine canand likely willplay a role in diagnostics, regenerative medicine, prosthetics and more, the effect the sub-discipline is currently having on the treatment of autoimmune diseases and cancers is significant.

Nanomedicine for HIVThirty years ago, a diagnosis of HIV/AIDS was essentially a guarantee of a painful, protracted death. It wasnt until 1996 that researchers discovered antiretroviral drugs, and the potent combination therapy that leads to successful management of HIV/AIDS in most cases. However, not much has changed since that discovery. Those suffering from the autoimmune disease still require daily oral dosing of three to four pills, and chronic oral dosing has significant complications that can arise from the high pill burden experienced by patients, leading to non-adherence to therapies for a variety of reasons.

Ive been working in HIV for over 20 years, Andrew Owen, professor of molecular and clinical pharmacology at the University of Liverpool (UK) told Laboratory Equipment. I was trying to understand the variability in drug exposure that occurs between different individuals and the genetic basis for that. We were finding a lot of interesting things, but they werent clinically implementable. They gave us a good understanding of why drug exposure was variable, but it didnt actually help the patients in any way.

In an attempt to solve the problem rather than just characterize it, Owen turned to nanomedicine in 2009, eventually becoming part of the first team to conduct human trials of orally dosed nanomedicines for HIV. Since then, Owen and his interdisciplinary team at the Liverpool Nanomedicine Partnership have secured more than 20 million of research funding for a multitude of nanomedicine-based approaches to HIV, such low-dose oral delivery, long-acting injectable medications and targeted delivery of antiretrovirals.

Some of Owens most important research to date tackles two of the pharmaceutical industrys biggest challenges: oral delivery of potent drugs and supply and demand.

One of the major problems that has plagued drug discovery and drug development over the last 30 years has been compatibility with oral drug delivery, Owen explained. The pharmaceutical industry has wrestled with that because they can develop very potent molecules across diseases, but actually delivering those molecules orally is very challenging. As you try to design into the molecule oral bioavailabilty, you usually get further away from the potency you want.

The Liverpool team solved this problem with the creation of Solid Drug Nanoparticles. The technology consists of combining a normal drug, in its solid form, with particles on that drug that are measurable within the nanometer scale. There are other things packed into the formulation as well, such as FDA-approved stabilizers that are proven to help disperse the drug. Owen says it is all about increasing the surface area covered by the drug.

If you imagine you take a granulated form of the drug, youre going to get big chunks of drugs in the intestinal tract when dissolution happens. But if you have nanometer-sized particles within the GI tract, then you are going to get a complete coating of the inside of the intestine after you take the drug, Owen explained. What that does is it massively increases the surface area covered by the drug, which saturates all sorts of drug influx processes within the GI tract.

Since 80 percent of a humans immune system is concentrated in the gut, the Solid Drug Nanoparticles are the perfect mechanism. The immune cells in the gut instinctually move toward the particles, creating a pathway for the drugs to cross the intestines, move through the lymphatic system, and finally into the systematic circulation.

In February, Owen presented the results of two trials at the Conference on Retroviruses and Opportunistic Infections (CROI) that confirmed his Solid Drug Nanoparticles can be effective at a 50 percent dose reduction. Specifically, Owen and his team applied the nanomedicine-based approach to the formulation of two drugs: efvirenz (EFV) and lopinavir (LPV). EFV is the current WHO-recommended regimen, with 70 percent of adult HIV patients in low- and middle-income countries taking the medication. At 50 percent of the dose, the patients in the trial were able to maintain plasma concentrations of the conventional dose.

Globally, the supply of drugs needed to treat every patient with HIV is outstripping manufacturing capabilitymeaning we, as a human species, cannot physically make enough HIV medication to treat everyone with the disease. A 50 percent reduction in dose means twice as many patients served with the existing drug supply.Owen and his team are working with multiple global partners to move the technology forward. For the drugs already formulated, the Medicines Patent Pool and Clinical Health Access are helping to scale up and take them to market. Meanwhile, USAIDs Project OPTIMIZE is applying the nanoparticle technology to the newest HIV drugs for use in low- and middle-income countries.

For their latest collaboration with Johns Hopkins University, the Liverpool team was just awarded $3 million to examine the use of implantable technologies that can deliver drugs for weeks, or even months.

The current oral drug regimens for HIV comprises three drugs in combinationone is the major driver for efficacy, and the other two are nucleoside reverse transcriptase inhibitors that prevent resistance to the main drug. However, current injectable formulations are only available with the main drugnone include the nucleoside reverse transcriptase inhibitors.

So, our project aims to develop the first long-acting injectable nucleoside reverse transcriptase inhibitors so that we can use them to have a fully long-acting regimen that matches the current clinical paradigm for therapy, Owen said.

The Liverpool/Hopkins team has also thought about applying their long-acting injectable technology to other chronic diseases, such as malaria and tuberculosis, as well as some cardiovascular applications.

Nanomedicine for diabetesWhen the nanoparticles he was working with as an imaging tool didnt produce the desired results, Pere Santamaria grew frustratedbut he didnt give up. Instead, the doctor and professor at the University of Calgary (Canada) changed his assumptions and pursued his experimentuntil the data came pouring in that confirmed it wasnt a failed experiment at all. Rather, it was a discovery.

The discovery of Navacims was a bit serendipitous, Santamaria told Laboratory Equipment. Thankfully I am a little OCD and I didnt let the failed experiment go.Navacims are an entirely new class of nanomedicine drugs that harness the ability to stop disease without impairing normal immunity. Santamaria has been studying Navacims for the past 17 years, ever since unintentionally developing them. He even started a spin-off company, Parvus Therapeutics, Inc., to help bring the drugs to market.

In autoimmune diseases, white blood cells, which are normally responsible for warding off foreign invaders and disease, turn on the body, attacking the good cells and causing their destruction. Each specific autoimmune disease results from an attack against thousands of individual protein fragments in the targeted organ, such as the insulin-producing pancreatic cells in the case of type 1 diabetes.

But Santamarias studies show that nanoparticles decorated with protein targets acting as bait for disease-causing white blood cells can actually be used to reprogram the cells to rightfully suppress the disease they once intended to cause.

Once the immune system recognizes the presence of a Navacim, a white blood cell is reprogrammed by epigenetic changes into a lymphocyte that no longer wants to cause tissue damage, but rather work to suppress disease. According to Santamaria, the reprogramming step is immediately followed by an expansion of that population of lymphocytesone now-good white blood cell dividing into a million.

Basically they turn the tables on the immune system, and then there is a very sophisticated series of downstream cellular events that arise from that reprogramming event that involves the recruitment of other lymphocytes and other cell types that completely suppress the inflammation in the organ that is being infected, Santamaria explained. This happens extremely efficiently and comprehensively. This is an approach that can efficiently, selectively and specifically blend a complex response without impairing basic immunity.

In addition, the design of Navacims is modular, meaning the nanomedicine can be applied to severalif not allautoimmune diseases, including multiple sclerosis and rheumatoid arthritis. Navacims can be altered to target different diseases by simply changing a small portion of the bait molecules on the nanoparticles. Santamarias studies have shown this to work in about seven autoimmune diseases thus far.

In April, Santamarias company Parvus entered into a license and collaboration agreement with Novartis for Navacims. Under the terms of the agreement, Novartis receives exclusive worldwide rights to use Parvus Navacim technology to develop and commercialize products for the treatment of type 1 diabetes, and will be responsible for clinical-stage development and commercialization. Parvus will still be responsible for conducting ongoing preclinical work in the diabetes area, with some research funding from Novartis.

Weve had such a long time to prove ourselves, that this is not a flash in the pan, that this is something serious and robust, Santamaria said. We know so much about the mechanisms of our actions, and so much granularity. I think there are no other drugs that have reached the clinic with this level of understanding. That was painful in the beginning for us, but in the end its going to be good.

Read more:
The Promise of Nanomedicine – Laboratory Equipment

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine | The Scientist Magazine


In a 1959 lecture at Caltech famously dubbed Theres Plenty of Room at the Bottom, American physicist and Nobel laureateto-be Richard Feynman discussed the idea of manipulating structures at the atomic level. Although the applications he discussed were theoretical at the time, his insights prophesied the discovery of many new properties at the nanometer scale that are not observed in materials at larger scales, paving the way for the ever-expanding field of nanomedicine. These days, the use of nanosize materials, comparable in dimension to some proteins, DNA, RNA, and oligosaccharides, is making waves in diverse biomedical fields, including biosensing, imaging, drug delivery, and even surgery.

Nanomaterials typically have high surface areato-volume ratios, generating a relatively large substrate for chemical attachment. Scientists have been able to create new surface characteristics for nanomaterials and have manipulated coating molecules to fine-tune the particles behaviors. Most nanomaterials can also penetrate living cells, providing the basis for nanocarrier delivery of biosensors or therapeutics. When systemically administered, nanomaterials are small enough that they dont clog blood vessels, but are larger than many small-molecule drugs, facilitating prolonged retention time in the circulatory system. With the ability to engineer synthetic DNA, scientists can now design and assemble nanostructures that take advantage of ?Watson-Crick base pairing to improve target detection and drug delivery.

Both the academic community and the pharmaceutical industry are making increasing investments of time and money in nanotherapeutics. Nearly 50 biomedical products incorporating nanoparticles are already on the market, and many more are moving through the pipeline, with dozens in Phase 2 or Phase 3 clinical trials. Drugmakers are well on their way to realizing the prediction of Christopher Guiffre, chief business officer at the Cambridge, Massachusettsbased nanotherapeutics company Cerulean Pharma, who last November forecast, Five years from now every pharma will have a nano program.

Technologies that enable improved cancer detection are constantly racing against the diseases they aim to diagnose, and when survival depends on early intervention, losing this race can be fatal. While detecting cancer biomarkers is the key to early diagnosis, the number of bona fide biomarkers that reliably reveal the presence of cancerous cells is low. To overcome this challenge, researchers are developing functional nanomaterials for more sensitive detection of intracellular metabolites, tumor cellmembrane proteins, and even cancer cells that are circulating in the bloodstream. (See Fighting Cancer with Nanomedicine, The Scientist, April 2014.)

The extreme brightness, excellent photostability, and ready modulation of silica nanoparticles, along with other advantages, make them particularly useful for molecular imaging and ultrasensitive detection.

Silica nanoparticles are one promising material for detecting specific molecular targets. Dye-doped silica nanoparticles contain a large quantity of dye molecules housed inside a silica matrix, giving an intense fluorescence signal that is up to 10,000 times greater than that of a single organic fluorophore. Taking advantage of Frster Resonance Energy Transfer (FRET), in which a photon emitted by one fluorophore can excite another nearby fluorophore, researchers can synthesize fluorescent silica nanoparticles with emission wavelengths that span a wide spectrum by simply modulating the ratio of the different dyesthe donor chromophore and the acceptor chromophore. The extreme brightness, excellent photostability, and ready modulation of silica nanoparticles, along with other advantages, make them particularly useful for molecular imaging and ultrasensitive detection.

THE NANOMEDICINE CABINET: Scientists are engineering nanometer-size particles made of diverse materials to aid in patient care. The unique properties of these structures are making waves in biomedical analysis and targeted therapy.See full infographic: JPG | PDF TAMI TOLPAOther materials that are under investigation as nanodetectors include graphene oxide (GO), the monolayer of graphite oxide, which has unique electronic, thermal, and mechanical properties. Semiconductor-material quantum dots (QDs), now being developed by Shuming Nies group at Emory University, exhibit quantum mechanical properties when covalently coupled to biomolecules and could improve cancer imaging and molecular profiling.1 Spherical nucleic acids (SNAs), in which nucleic acids are oriented in a spherical geometry, scaffolded on a nanoparticle core (which may be retained or dissolved), are also gaining traction by the pioneering work of Chad Mirkins group at Northwestern University.2 (See illustration.)

Nanoparticles are also proving their worth as probes for various types of bioimaging, including fluorescence, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). For instance, Xiaoyuan Chen, now at the National Institutes of Healths National Institute of Biomedical Imaging and Bioengineering, and Hongjie Dai of Stanford University have developed carbon nanotubes for performing PET scans in mice. When modified with the macromolecule polyethylene glycol to improve biocompatibility, the nanotubes were very stable and remained in circulation for days, far longer than the few hours typical of many molecular imaging agents.3 Further modification with a short-peptide targeting ligand called RGD caused the nanotubes to selectively accumulate in tumors that overexpressed integrin, the molecular target of RGD, enabling precise tumor imaging.

To further increase the specificity of nanodetectors, researchers can add recognition probes such as aptamersshort synthetic nucleic acid strands that bind target molecules. For example, we conjugated gold nanoparticles with aptamers that had been identified through iteratively screening DNA probes using living cancer cells.4 Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors and provide a potential target for early cancer diagnosis. However, CTCs are rare, with blood concentrations of typically fewer than 10 cells per milliliter of blood. Collaborating with physicians to profile samples from leukemia patients, we demonstrated that aptamers are capable of differentiating among different subtypes of leukemia, as well as among patient samples before and after chemotherapy (unpublished data). In addition to leukemia, we have selected aptamers specific to cancers of the lung, liver, ovaries, colon, brain, breast, and pancreas, as well as to bacterial cells. Other researchers have developed nanoparticles with numerous and diverse surface aptamers, enabling them to bind their targets more efficiently and securely.

NANOCAPSULES: A false-color transmission electron micrograph of liposomes, spherical particles composed of a lipid bilayer around a central cavity that can be engineered to deliver both hydrophobic and hydrophilic drugs to specific cells in the body DAVID MCCARTHY/SCIENCE SOURCEThe prototype of targeted drug delivery can be traced back to the concept of a magic bullet, proposed by chemotherapy pioneer and 1908 Nobel laureate Paul Ehrlich. Ehrlich envisioned a drug that could selectively target a disease-causing organism or diseased cells, leaving healthy tissue unharmed. A century later, researchers are developing many types of nanoscale magic bullets that can specifically deliver drugs into target cells or tissues.

Doxil, the first nanotherapeutic approved by the US Food and Drug Administration, is a liposome (~100 nm in diameter) containing the widely used anticancer drug doxorubicin. The therapy takes advantage of the leaky blood vasculature and poor lymphatic drainage in tumor tissues that allow the nanoparticles to squeeze from blood vessels into a tumor and stay there for hours or days. Scientists have also been developing nanotherapeutics capable of targeting specific cell types by binding to surface biomarkers on diseased cells. Targeting ligands range from macromolecules, such as antibodies and aptamers, to small molecules, such as folate, that bind to receptors overexpressed in many types of cancers.

Aptamers in particular are a popular tool for targeting specific cells. Aptamer development is efficient and cost-effective, as automated nucleic acid synthesis allows easy, affordable chemical synthesis and modification of functional moieties. Other advantages include high stability and long shelf life, rapid tissue penetration based on the relatively small molecular weights, low immunogenicity, and ease of antidote development in the case of an adverse reaction to therapy by simply administering an aptamers complementary DNA. We have demonstrated the principle of modifying aptamers on the surfaces of doxorubicin-containing liposomes, which then selectively delivered the drug to cultured cancer cells.5

Recent advances in predicting the secondary structures of a DNA fragment or interactions between multiple DNA strands, as well as in technologies to automatically synthesize predesigned DNA sequences, has opened the door to more advanced applications of aptamers and other DNA structures in nanomedicine. For instance, we have developed aptamer-tethered DNA nanotrains, assembled from multiple copies of short DNA building blocks. On one end, an aptamer moiety allows specific target cell recognition during drug delivery, and a long double-stranded DNA section on the other end forms the boxcars for drug loading. The nanotrains, which can hold a high drug payload and specifically deliver anticancer drugs into target cancer cells in culture and animal models,6 could reduce drug side effects while inhibiting tumor growth. Alternatively, Daniel Anderson of MIT engineered a tetrahedral cage of DNA, often called DNA origami, for folate-mediated targeted delivery of small interfering RNAs (siRNAs) to silence some tumor genes.7 And Mirkins SNAs can similarly transport siRNAs as guided missiles to knock out overexpressed genes in cancer cells. Mirkins group also recently demonstrated that the SNAs were able to penetrate the blood-brain barrier and specifically target genes in the brains of glioblastoma animal models.2 Peng Yin of Harvard Medical School and the Wyss Institute and others are now building even more complex DNA nanostructures with refined functions, such as smart biomedical analysis.8

Conventional assembly of such DNA nanostructures exploits the hybridization of a DNA strand to part of its complementary strand. In addition, we have discovered that DNA nanostructures called nanoflowers because they resemble a ring of nanosize petals, can be self-assembled through liquid crystallization of DNA, which typically occurs at high concentrations of the nucleic acid.9 Importantly, these DNA nanostructures can be readily incorporated with components possessing multiple functionalities, such as aptamers for specific recognition, fluorophores for molecular imaging, and DNA therapeutics for disease therapy.

Another example of novel nanoparticles is DNA micelles, three-dimensional nanostructures that can be readily modified to include aptamers for specific cell-type recognition, or DNA antisense for gene silencing. The lipid core and sphere of projecting nucleic acids can enter cells without any transfection agents and have high resistance to nuclease digestion, making them ideal candidates for drug delivery and cancer therapy.

Researchers are developing many types of nanoscale magic bullets that can specifically deliver drugs into target cells or tissues.

Such advances in targeting are now making it possible to deliver combinations of drugs and ensure that they reach target cells simultaneously. Paula Hammond and Michael Yaffe of MIT recently reported a liposome-based combination chemotherapy delivery system that can simultaneously deliver two synergistic chemotherapeutic drugs, erlotinib and doxorubicin, for enhanced tumor killing.10 Erlotinib, an inhibitor of epidermal growth factor receptor (EGFR), promotes the dynamic rewiring of apoptotic pathways, which then sensitizes cancer cells to subsequent exposure to the DNA-damaging agent doxorubicin. By incorporating erlotinib, a hydrophobic molecule, into the lipid bilayer shell while packaging the hydrophilic doxorubicin inside of the liposomes, the researchers achieved the desired time sequence of drug releasefirst erlotinib, then doxorubicinin a one-two punch against the cancer. They also demonstrated that the efficiency of drug delivery to cancer cells was enhanced by coating the liposomes with folate.

Scientists are also engineering smart nanoparticles, which activate only in the disease microenvironment. For example, George Church of Harvard Medical School and the Wyss Institute and colleagues invented a logic-gated DNA nanocapsule that they programmed to deliver drugs inside cells only when a specific panel of disease biomarkers is overexpressed on the cell surface.11 And Donald Ingbers group, also at Harvard Medical School and the Wyss Institute, developed microscale aggregates of thrombolytic-drug-coated nanoparticles that break apart under the abnormally high fluid shear stress of narrowed blood vessels and then bind and dissolve the problematic clot.12

With these and other nanoplatforms for targeted drug delivery being tested in animal models, medicine is now approaching the prototypic magic bullet, sparing healthy tissue while exterminating disease.

In addition to serving as mere drug carriers that deliver the toxic payload to target cells, nanomaterials can themselves function as therapeutics. For example, thermal energy is emerging as an important means of therapy, and many gold nanomaterials can convert photons into thermal energy for targeted photothermal therapy. Taking advantage of these properties, we conjugated aptamers onto the surfaces of gold-silver nanorods, which efficiently absorb near-infrared light and convert energy from photons to heat. These aptamer-conjugated nanorods were capable of selectively binding to target cells in culture and inducing dramatic cytotoxicity by converting laser light to heat.13

Magnetic nanoparticles are also attractive for their ability to mediate heat induction. Jinwoo Cheon of Yonsei University in Korea developed coreshell magnetic nanoparticles, which efficiently generated thermal energy by a magnetization-reversal process as these nanoparticles returned to their relaxed states under an external, alternating-current magnetic field.14 Using this technology, Cheon and his colleagues saw dramatic tumor regression in a mouse model.A third type of nanosize therapeutic involves cytotoxic polymers. For example, we synthesized a nucleotide-like molecule called an acrydite with an attached DNA aptamer that specifically binds to and enters target cancer cells.15 The acrydite molecules in the resultant acrydite-aptamer conjugates polymerized with each other to form an aptamer-decorated molecular string that led to cytotoxicity in target cancer cells, including those exhibiting multidrug resistance, a common challenge in cancer chemotherapy.

Many other subfields have been advanced by recent developments in nanomedicine, including tissue engineering and regenerative medicine, medical devices, and vaccines. We must proceed with caution until these different technologies prove safe in patients, but nanomedicine is now poised to make a tremendous impact on health care and the practice of clinical medicine.

Guizhi Zhu is a postdoctoral associate in the Department of Chemistry and at the Health Cancer Center of the University of Florida. Weihong Tan is a professor and associate director of the Center for Research at the Bio/Nano Interface at the University of Florida. He also serves as the director of the Molecular Science and Biomedicine Laboratory at Hunan University in China, where Lei Mei is a graduate student.

See more here:
Nanomedicine | The Scientist Magazine

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Conferences | Nanotechnology Events …

About Conference

ME Conferences invites all the participants from all over the world to attendNanomedicine and Nanotechnology in Health CareDuring 17-19 September, 2018 at Abu Dhabi, UAE. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. And it provides an opportunity to learn about the complexity of the Diseases, discuss interventional procedures, look at new and advances in Nanotechnology and their efficiency and efficacy in diagnosing and treating various diseases and also in Healthcare treatments.

ME Conferences organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 1,00,000 eminent personalities, reputed scientists as editorial board and organizing committee members. ME Conferences journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.ME Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, international workshops, world class international exhibitions and poster presentations.

Why to attend?

This Conference Nanomedicinemeet 2018 will focus on Healthcare and Medicine. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nanotechnology and Engineering, Medical Nanotechnology, Tissue Engineering are hallmarks of this conference. Nanomedicinemeet-2018 is an exciting opportunity to showcase the modern technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanotechnology, MaterialScienceand other interesting topics.

Target Audience:

The termNano medicineencompasses a broad range of technologies and materials. Types of nanomaterials that have been investigated for use as drugs,, drug carriersor other Nonmedical agents. There has been steep growth in development of devices that integrate nanomaterials or other nanotechnology. Thenanotechnology-based medical devices market is categorized into three major segments, namely, therapeutic applications, diagnostics applications, and research applications. Rising incidence of lifestyle and age-related disorders (such as cardiovascular and hearing disorders) has contributed significantly to the growth of the nanotechnology-based active implantable devices market. Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medicine, communications and genomics. On the surface, miniaturization provides cost effective and more rapidlyfunctioningbiological components. Less obvious though is the fact that Nanometer sized objects also possess remarkableself-ordering and assemblybehaviors under the control of forces quite different from macro objects.

Advances in technology have increased our ability to manipulate the world around us . Nanotechnology is rapidly emerging within the realm of medicine. Nanomedicine is the process of diagnosing, treating, and preventing disease andtraumatic injury, of relieving pain, and of preserving and improving human health, using molecular tools and molecular knowledge of the human body. An exciting and promising area of Nano technological development is the building of Nanorobots. Highly precise positioning techniques are required in Miniaturing in chip technology, optics , micro mechanic, medicine , gene and biotechnology. The new manipulation technology is the desire to enter the micro and Nano world not only by viewing but also acting, alteringmicro andNanosized objects. Nanorobots plays a critical roles for many applications in the human body, such astargetingtumoral lesionsfor therapeutic purposes, miniaturization of the power source with an effective onboard controllable propulsion and steering system have prevented the implementation of such mobile robots.

The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed. It is an emerging modality for the treatment of a variety of diseases that require the killing of pathological cells (e.g. cancer cells or infectious micro-organisms) or the removal of unwanted tissue (e.g. neovascularization in the choroid or atherosclerotic plaques in the arteries). It is based on the excitation of nontoxic photosensitizers.Photodynamic therapy(PDT) uses the combination of dyes with visible light to produce reactive oxygen species and kill bacteria and destroy unwanted tissue. Nanotechnology plays a great role insolubilizing thephotosensitizers, metal nanoparticles can carry out Plasmon resonance enhancement, andfullerenescan act as photosensitizers, themselves.

Nanotechnology is becoming increasingly important for the several sectors. Promising results and applications are already being developed in the areas of nutrient delivery systems through bioactive Nano encapsulation,biosensorsto detect and quantifypathogens organic compounds. The sensitivity and performance of biosensors is being improved by using nanomaterials for their construction. The use of these nanomaterials has allowed the introduction of many new signal transduction technologies in biosensors. Many scientists have involved themselves to know the application and the benefits of nanotechnology in different areas of food industry that include bioactive Nano encapsulation, edible thin film, packages andNano sensors.

Green chemistry and Nano science are both emerging fields that take advantage of molecular-level designing and have enormous potential for advancing our science. Nano science is the study of materials that are on the length-scale of 100 nanometers or smaller and have properties that are dependent on their physical size. The principles of green chemistry can guide responsible development of Nano science, while the new strategies of Nano science can fuel the development ofgreener productsand processes.Phytochemicalsoccluded in tea have been extensively used as dietary supplements and as naturalpharmaceuticalsin the treatment The parallel development of green chemistry and Nano science and the potential synergy of the two fields can lead to more successful and profitable technologies with reduced environmental impacts and improved conservation of resources. In recent years, green synthesis ofmetal nanoparticlesis an interesting issue of the nanoscience.

Nanotechnologyis enabling technology that deals with Nano-meter sized objects. It is expected that nanotechnology will be developed at several levels: materials, devices and systems. The combination of biology and nanotechnology has led to a new generation ofNano devicesthat opens the possibility to characterize the chemical, physical, mechanical, and other molecular properties. And it can be even used to characterize the single molecules or cells at extraordinarily high throughput.Nanoparticleswith distinctive chemical compositions, sizes, shapes, and surface chemistries can be engineered easily and this technique has wide range of applications in biological systems.Utility of nanotechnology to biomedical sciences imply creation of materials and devices designed tointeraction in sub-cellular scaleswith a high degree of specificity.

Biopolymer nanoparticles are offering numerous advantages which embrace the simplicity of their preparation from well-understood biodegradable, biocompatible polymers and their high stability inbiological fluidsduring storage. Since the emergence of Nanotechnology in the past decades, the development and design of organic andbioorganic nanomaterialshas become an important field of research. And several types of polymers have been tested and are used in drug delivery systems; including nanoparticles, dendrimers, capsosomes and micelles. Researchers have found, the synthesized polymers even serves as a good carrier and plays a vital role in carrying a drug. And in other hand they are used in food industries too for food package purposes. There are thousands of organic chemicals are in present in various pharmaceutical to consumer product and are being used in dyes, flavoring agents. It can be explained in organic compounds ranging in diameter from 10 to 1m.Ultrafine particlesare the same asnanoparticlesand between 1 and 100 nanometers in size, fine particles are sized between 100 and 2,500 nanometers, and coarse particles cover a range between 2,500 and 10,000nanometers.

The biological synthesis ofnanoparticlesis synthesis method through which we can control, size and shape of nanoparticles and it increasingly regarded as a rapid, ecofriendly, and easily scaled-up technology. Over the past few years researches have shown their interest inmetallic nanoparticlesand their synthesis has greatly increased. However, drawbacks such as the involvement oftoxic chemicalsand the high-energy requirements of production. Synthesizing living organisms such as bacteria, fungi and plants is an alternative way to overcome the drawbacks. Plant mediated synthesis of nanoparticles is the green chemistry that connects. Generally, metal nanoparticles are synthesized and stabilized by using physical and chemical: the chemical approach, such as chemical reduction,electrochemical techniques,photochemical reactionsin reverse micelles. There is a growing attention to biosynthesis the metal nanoparticles using organisms. Among these organisms, plants seem to be the best candidate and they are suitable for large scale biosynthesis of nanoparticles.

Nanoparticles used asdrug deliveryvehicles are generally below 100 nm , and are coated with different biodegradable materials such as natural or synthetic polymers (PEG,PVA,PLGA,etc.), lipids, or metals , it plays significant role on cancer treatment as well as it holds tremendous potential as an effective drug delivery system. A targeted drug delivery system (TDDS) is a system, which releases the drug in a controlled manner. Nanosystems with different compositions and biological properties have been extensively investigated for drug and gene delivery applications. To achieve efficient drug delivery it is important to understand the interactions ofNanomaterialswith the biological environment, targetingcell-surface receptors, drug release, multiple drug administration, stability of therapeutic agents. Nanotechnology refers to structures roughly in the 1100 nm size regime in at least one dimension. Despite this size restriction, nanotechnology commonly refers to structures that are up to several hundred nanometers in size and that are developed bytop-down or bottom-up engineering of individual components.

Nanosuspention formulation can be used to improve the solubility of the poorly soluble drugs. One of the major problems associated with poorly soluble drugs is very low bioavailability. The Preparation ofNanosuspentionis simple and applicable to all drugs which are water insoluble. It consists of the pure poorly water-soluble drug without any matrix material suspended in dispersion . Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction,crystal engineering, salt formation, solid dispersion, use ofsurfactant, complexation A range of parameters like solubility, stability at room temperature, compatibility with solvent, excipient, andphotostabilityplay a critical role in the successful formulation of drugs. Use of some drug which is potentially restricted because of its toxic side-effects and its poor solubility, making it unsuitable for intravenous use in patients withdrug malabsorption.

Nano medicine drives the convergence of nanotechnology and medicine it is delineated as the application of nanotechnology in healthcare. The field of tissue engineering has developed in phases: initially researchers searched for inert biomaterialsto act solely as replacement structures in the body. Tissue engineering is classified as an associate field of biomaterialsand engineering. It focuses on the use of cellular and material-based therapies aimed attargeted tissue regenerationcaused by traumatic, degenerative, and genetic disorders.It covers a broad range of applications, in practice the term has come to represent applications that repair or replace structural tissues (i.e., bone, cartilage, blood vessels, bladder, etc.). Today, these Nano scale technologies are coming to the forefront in medicine because of their biocompatibility, tissue-specificity, and integration and ability to act as therapeutic carriers.

Polymeric nanoparticles (NPs) are one of the most studied organic strategies for Nano medicine. Intense interest lies in the potential ofpolymeric NPsto revolutionize modern medicine. Polymeric NPs include drug delivery techniques such as conjugation and entrapment of drugs,prodrugs, stimuli-responsive systems,imaging modalities, and theranostics.The use of biodegradable polymeric nanoparticles (NPs) for controlled drug delivery has shown significanttherapeutic potential. Concurrently, targeted delivery technologies are becoming increasingly important as a scientific area of investigation. Polymericnanoparticles-based therapeutics show great promise in the treatment of a wide range of diseases, due to the flexibility in which their structures can be modified, with intricate definition over their compositions, structures and properties. Advances in polymerizationchemistries and the application of reactive, efficient andorthogonal chemicalmodification reactionshave enabled the engineering of multifunctional polymericnanoparticles.

In recent years,microbubbleand Nano bubble technologies have drawn great attention due to their wide applications in many fields of science and technology, such as water treatment,biomedical engineering, and nanomaterials.Nano bubblesexhibit unique characteristics; due to their minute size and high internal pressure, they can remain stable in water for prolonged periods of time. Nanobubbles can be created whengold nanoparticlesare struck by short laser pulses. The short-lived bubbles are very bright and can be made smaller or larger by varying the power of the laser. Because they are visible under a microscope, nanobubbles can be used to either diagnose sick cells or to track the explosions that are destroying them.

Natural productshave been used in medicine for many years. Many top-sellingpharmaceuticalsare natural compounds or their derivatives.. And plant- or microorganism-derived compounds have shown potential as therapeutic agents against cancer, microbial infection, inflammation, and other disease conditions. Natural products had huge success in the post-World War II era as antibiotics, and the two terms have become synonymous.While large pharmaceutical companies have favored screening synthetic compound libraries for drug discovery, small companies have started to explore natural products uses against cancer, microbial infection, inflammation, and other diseases.The incorporation of nanoparticles into a delivery system for natural products would be a major advance in the efforts to increase their therapeutic effects. Recently, advances have been made showing that nanoparticles can significantly increase the bioavailability of natural products bothin vitro and in vivo.

Nanoscience and nanotechnology are new frontiers of this century and food nanotechnology is an emerging technology. Food technology is regarded as one of the industry sectors where nanotechnology will play an important role in the future. The development of new products and applications involving nanotechnologies holds great promise in different industrial sectors, Nanotechnology may revolutionize the food industry by providing stronger, high-barrier packaging materials, more potentantimicrobial agents. Several possibilities exist to exploit the benefits of nanotechnologies during different phases of the food chain with the aim to enhance animal nutrition and health. Several complex set of engineering and scientific challenges in the food and bioprocessing industries for manufacturing high quality and safe food through efficient and sustainable means can be solved through nanotechnology. Bacteria identification and food quality monitoring using biosensors; intelligent, active, and smart food packaging systems; and Nanoencapsulationofbioactive food compoundsare few examples of emerging applications of nanotechnology for the food industry.

The main current applications of Nanotechnology for surgeons are in the areas of development of surgical implants using Nanomaterials, Imaging, Drug Delivery and development of Tissue Engineering products, such as scaffolds with enhanced materialcell interaction. An example of this is the development of a scaffold for delivery of stem cells to replace defective retinal pigmented epithelial cells in age-related Macular Degeneration. In Dentistry research has been done, liposomal Nanoparticles that contained collagenase and performed tests with them in rats, and found compared to conventional surgery, collagenase weakened the collagen fibers, making it easier to shift the teeth afterward with braces.

Nanoparticles with their unique size-dependent properties are at the forefront of advanced material engineering applications in several fields. Metals, non-metals, bio-ceramics, and manypolymeric materialsare used to produce nanoparticles of the respective materials. These are functional in producing liposomes, PEG and many more. Due to their small size nanoparticles has found to be interacting with human bodies same like of gases. Nanoparticles of the same composition can display behavioral differences when interacting with different environments. Nanoparticles can enter the human body via inhalation, ingestion, or skin contact. The range of pathologiesrelated to exposure tonanoparticles encompasses respiratoryand even several organs and leads to diseases. Accurate in vitro assessment ofnanoparticle cytotoxicityrequires a careful selection of the test systems. Due to high adsorption capacity and optical activity, engineered nanoparticles are highly potential in influencing classical cytotoxicity assays.

One of the exciting features of nanotechnology is its utility in the field of Nano medicine, therapeutics, and medical devices . When these small size materials are introduced into biological systems, their extremely small size and their unique Nano scale properties make it possible to use them as delivery vectors and probes for biological diagnostics,bioimagingand therapeutics. In fact, when size decreases, thesurface area to volume ratioof materials becomes very large, so that a vast suitable surface is available forchemical interactions withbiomolecules. This critically implied that nanotechnology is facing a transition into the tangible advancement ofhuman therapeutics. Recently, There are multiple clinical trials of nanomaterials have done; both for therapeutics and for medical devices.

Related conferences: Nanomedicine Conferences | Nanotechnology Events | Nano Healthcare Congress | Nanomedicine Meet | Nanoscience Event | Nanoengineering Conference | Tissue Engineering Meeting

Related Societies:

USA:International Organization of Materials, International Association of Nanotechnology, Graphene Stakeholders Association, Nano Science and Technology Institute (NSTI),NanoBusiness Commercialization Association, Alliance for Nanotechnology in Cancer,International association of nanotechnology,National Institute for Nanotechnology, Waterloo Institute for Nanotechnology, The Institute for Molecular Manufacturing (IMM),NanoBusiness Alliance, Nanotechnology and Nanoscience Student Association (NANSA),Nano Science and Technology Institute (NSTI),National Cancer Institute, National Nanotechnology Initiative,American Nano society, Metals and Minerals Societies, Society for Advancement of Material and process Engineering,American Composites Manufacturers Association, Brazilian Composites Materials Association,Canadian Biomaterials Society, American Institute of Aeronautics and Astronautics (AIAA).

Europe:International Union of Crystallography, European Nanoscience and Nanotechnology Association (ENNA),German Association of Nanotechnology, Nanotechnology Industries Association, The Institute of Nanotechnology (IoN), Nanotechnology Industries Association (NIA),Russian Society of Scanning Probe Microscopy and Nanotechnology, Society of Nanoscience and Nanotechnology, Federation of Materials Societies, Society for Biomaterials, Federation of European Materials Societies

Asia-Pacific & Middle East:Nano Technology Research Association (NTRA), Asian Nanoscience and Nanotechnology Association (ANNA), Nanoscience & Nanotechnology, ASPEN-Asian society of precision engineering and nanotechology, The International Association of Nanotechnology (IANT), Iran Nanotechnology Initiative Council (INIC), National Institutes of Health, Society of Materials Science, Japan Society for Composite Materials, Australasian Society for Biomaterials and Tissue Engineering, Australasian Ceramic Society, Materials Research Society, National Centre for Nanoscience and Technology.

Theme: Role of Nanotechnology in Humans life


The field of Nanotechnology has recently emerged as the most commercially viable technology of this century because of its wide-ranging applications in our daily lives. Man-made Nanostructured materials such as fullerenes, nanoparticles, Nano powders, Nanotubes, Nanowires, Nanorods, Nano-fibers, Quantum dots, Dendrimers, Nano clusters, Nanocrystals, and Nanocomposites are globally produced in large quantities due to their wide potential applications, e.g., in skincare and consumer products, healthcare, electronics, photonics, biotechnology, engineering products, Pharmaceuticals, drug delivery, and agriculture. Many emerging economies such as Brazil, China, India, Iran, UAE, Malaysia, Mexico, Singapore and South Africa have ambitious research and development (R&D) plans for Nanotechnology.A group of scientists who have mapped out the uses of Nanotechnology and the needs of global health argue that Nano medicine is relevant for the developing world. They surveyed researchers worldwide and concluded that Nanotechnology could greatly contribute to meeting the Millennium Development Goals for health.

Importance and scope:

Nanotechnologyis becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including Nano scale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies. Universities also have begun to offer dedicated Nano medicine degree programs (example:MSc program in Nanotechnology for Medicine and Health Care). Nanotechnology will be getting to be progressively prevalent these times Around learners. Actually, if you follow again of the Inception about nanotechnology, you will discover that Ayurveda need long been utilizing gold Also silver nanoparticles, known as bhasmas, to treat Different therapeutic ailments. Presently, nanotechnology may be generally utilized within huge numbers industries, going from cosmetics, agriculture, and materials should pharmaceutical Also human services. Nanomedicine may be the provision for nanotechnology for those diagnoses, detection, and medicine Also aversion of illnesses. Presently there need aid various items on the business that would the outcome from claiming nanotechnology. Talking for scratching the surface, we likewise have Nano auto wax that fills done the individuals minor cracks more successfully Furthermore provides for you a shinier vehicle. There need aid likewise Nano items accessible with stay with your eyewear What’s more different optical units cleaner, dryer, What’s more that’s only the tip of the iceberg tough.

Conference highlights:

Why in Abu Dhabi?

Abu Dhabi is the federal capital and centre of government in the United Arab Emirates sits off the mainland on an island in the Persian (Arabian) Gulf. It is the largest city of the Emirate of Abu Dhabi and one of the most modern cities in the world. It is a well-ordered, industrious city with a pretty waterside location. Innovative Nano Technology LLC was founded in the beginning of 2016 in Al Ain City, Abu Dhabi, United Arab Emirates. It was established with the goal of taking a leading role in the field of Nano Technology Based Coatings, and is considered as one of the first Companies who offer the new Nano technology based Coatings in the region.

Why to attend?

United Arab Emirates has a number of universities that offer research and educational opportunities in nanotechnology. United Arab Emirates University, The first and foremost comprehensive National University in the United Arab Emirates. eFORS office is the University consultancy office within the college of engineering that deals with several science and technology issues including Biochemical and Biopharmaceutical Processes and Bioengineering and Nanotechnology. Reports released during October 2012 revealed that the worlds second largest foundry, Globalfoundries has agreed to partner with Masdar Institute to develop Abu Dhabi as a centre for semiconductor R&D and manufacturing excellence. In September, the company allowed students and professors to use its technology facilities at its Abu Dhabi branch. The facilities have a laboratory-like environment with powerful production servers, engineering work stations and a high-speed data network that can be used for enabling remote access to very advanced nanotechnology engineering systems

Technology domains of patent applications in UAE

This graph shows the global Nanomedicine market size, measured in terms of revenues, such as sales revenues, grants revenues, and milestones. From2006to date, a steady growth has occurred, which is expected to continue through2014, at aCAGRof13.5% [BCCResearch, Nanotechnology in Medical Applications. The drug delivery market is the largest contributing application segment, whereas biomaterials are the fastest growing application area in this market. Nanomedicine accounts for77Marketed Products Worldwide, representing an Industry with an estimated market $249.9Billion by2016[ETPNdata,BCC].

Globally, the industry players would centering essentially once R&D to get Regard for Different clinical trials for future Nanodrugs with a chance to be economically accessible in the business sector. If a chance to be generally arranged for exactly of the most punctual What’s more The greater part essential requisitions of Nano medicine for regions for example, gene treatment and tissue building. The a greater amount propelled requisitions for Nano medicine will pose interesting tests As far as order Furthermore support about exploratory dexterity.

Nano medicine market :

Nano-enabled medical products beganappearing on the market over a decade ago and some have become best-sellers in theirtherapeutic categories. The main areas in which Nanomedical products have made animpact are cancer, CNS diseases, cardiovascular disease, and infection control. At present, cancer is one of the largesttherapeutic areas in which Nano-enabled products have made major contributions; theseinclude Abraxane, Depocyt, Oncospar, Doxil,and Neulasta. Cancer is a prime focus forNano pharmaceutical R&D, and companieswith clinical-stage developments in this fieldinclude Celgene, Access, Camurus, andCytimmune. Treatments for CNS disorders includingAlzheimers disease and stroke also feature prominently in Nano therapeutic research,seeking to build on achievements already posted by products such as Tysabri, Copazone,and Diprivan. According to BCC Research,this is a field hungry for successfultherapeutic advances and annual growth fromexisting and advanced pipeline products isexpected to reach 16% over the next 5 years.

Nanotechnology Companies in Asia and Middle East:

Nano Congress 2017

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Sponsors for making Nano Congress 2017 Conference the best ever!

The19thNano Congress for Next Generation, hosted by the ME Conferences was held duringAugust 31- September 01, 2017atBrussels, Belgiumbased on the themeNext Generation Nanotechnology Concepts Methodologies Tools and Applications”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Nanotechnology who made this event a grand success.

ME Conferences expresses its gratitude to the conference Moderator,namelyDr.Dominique Ausserrefor taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judge namely,Dr. Arturs Medvids.

The conference was initiated with theHonorable presenceof theKeynote forum. The list includes:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Nano Materials Synthesis and Characterisation

Nano Photonics

Molecular Nanotechnology

Nanotechnology and Cosmetics

Nanotechnology in Agriculture and Food Industry

Carbon Based Nano materials and Devices

Nanotechnology Safety

Nano Medicine and Nano Biotechnology

Nano Science and Technology

Nano Applications


Nano Biomaterials

Nano Biometric

Advanced Nanomaterials

Nano Technology in Tissue Engineering

Nanotech for Energy and Environment

Nano Computational Modelling

ME Conferences offers its heartfelt appreciation to organizations such asAllied Academies,Andrew John Publishing Inc.,New York private Equity Forum,Crowd Reviewsand other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. ME Conferences also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and sponsors who supported this event

Read the rest here:
Nanomedicine Conferences | Nanotechnology Events …

Recommendation and review posted by Alexandra Lee Anderson

OMICS International | Open Access Journals | Scientific …

Select JournalSELECT fullname, submit_url FROM `journal_urls` order by fullname Abnormal and Behavioural Psychology Acute and Chronic Disease Reports Advanced Practices in Nursing Advanced Techniques in Biology & Medicine Advancements in Genetic Engineering Advances in Automobile Engineering Advances in Antibiotics & Antibodies Advances in Cancer Prevention Advances in Crop Science and Technology Advances in Dairy Research Advances in Molecular Diagnostics Advances in Pharmacoepidemiology & Drug Safety Advances in Recycling & Waste Management Advances in Robotics & Automation Aerobics & Fitness Agrotechnology Air & Water Borne Diseases Alternative & Integrative Medicine Anatomy & Physiology: Current Research Andrology-Open Access Anesthesiology Communications Angiology: Open Access Annals of Infections and Antibiotics Anthropology Applied Microbiology: Open Access Arabian Journal of Business and Management Review Archives of Parasitology Archives of Science Archives of Surgical Oncology Arts and Social Sciences Journal Atherosclerosis: Open Access Autism-Open Access Bioceramics Development and Applications Biochemistry & Analytical Biochemistry Biochemistry & Pharmacology: Open Access Biochemistry & Physiology: Open Access Bioenergetics: Open Access Biological Systems: Open Access Biology and Medicine Biopolymers Research Biosensors Journal Bipolar Disorder: Open Access Brain Disorders & Therapy Breast Cancer: Current Research Business and Economics Journal Cancer Surgery Cardiovascular Pharmacology: Open Access Cardiovascular Therapy: Open Access Cell & Developmental Biology Cellular and Molecular Biology Chemical Sciences Journal Chemotherapy: Open Access Clinical & Medical Biochemistry Clinical and Experimental Psychology Clinical and Medical Case Reports Clinical Depression Clinical Gastroenterology Journal Clinical Infectious Diseases: Open Access Clinical Microbiology: Open Access Clinical Neuropsychology: Open Access Clinical Pediatrics: Open Access Clinical Pharmacology & Biopharmaceutics Clinical Research on Foot & Ankle Clinics in Mother and Child Health Cloning & Transgenesis Cosmetology & Oro Facial Surgery Current Synthetic and Systems Biology Current Trends in Gynecologic Oncology Dentistry Dermatology and Dermatologic Diseases Dermatology Case Reports Diabetes Case Reports Diagnostic Pathology: Open Access Drug Designing: Open Access Emergency Medicine: Open Access Endocrinology & Metabolic Syndrome Entomology, Ornithology & Herpetology: Current Research Environment Pollution and Climate Change Enzyme Engineering Epidemiology: Open Access Epigenetics Research: Open Access Epilepsy Journal Evidence based Medicine and Practice Family Medicine & Medical Science Research Fermentation Technology Fibromyalgia: Open Access Fisheries and Aquaculture Journal Fluid Mechanics: Open Access Forest Research: Open Access Fungal Genomics & Biology Gene Technology General Medicine: Open Access Global Journal of Nursing & Forensic Studies Global Journal of Technology and Optimization Gynecology & Obstetrics Hair Therapy & Transplantation Health Care : Current Reviews Health Economics & Outcome Research: Open Access Hepatology and Pancreatic Science Hereditary Genetics: Current Research HIV: Current Research Human Genetics & Embryology Hydrology: Current Research Immunochemistry & Immunopathology Immunogenetics: Open Access Immunological Disorders & Immunotherapy Immunology: Current Research Immunome Research Immunotherapy: Open Access Industrial Chemistry Industrial Engineering & Management Innovative Energy & Research Intellectual Property Rights: Open Access Internal Medicine: Open Access International Journal of Accounting Research International Journal of Advance Innovations, Thoughts & Ideas International Journal of Advancements in Technology International Journal of Biomedical Data Mining International Journal of Economics & Management Sciences International Journal of Emergency Mental Health and Human Resilience International Journal of Inflammation, Cancer and Integrative Therapy International Journal of Microscopy International Journal of Neurorehabilitation International Journal of Physical Medicine & Rehabilitation International Journal of Public Health and Safety International Journal of Research and Development in Pharmacy & Life Sciences International Journal of School and Cognitive Psychology International Journal of Sensor Networks and Data Communications International Journal of Swarm Intelligence and Evolutionary Computation International Journal of Waste Resources Irrigation & Drainage Systems Engineering JBR Journal of Clinical Diagnosis and Research JBR Journal of Interdisciplinary Medicine and Dental Science Journal of Accounting & Marketing Journal of Addiction Research & Therapy Journal of Advanced Chemical Engineering Journal of Aeronautics & Aerospace Engineering Journal of Aging Science Journal of Agricultural Science and Food Research Journal of AIDS & Clinical Research Journal of Alcoholism & Drug Dependence Journal of Allergy & Therapy Journal of Alzheimers Disease & Parkinsonism Journal of Analytical & Bioanalytical Techniques Journal of Anesthesia & Clinical Research Journal of Anesthesiology and Pain Research Journal of Animal Health and Behavioural Science Journal of Anthropology Reports Journal of Antimicrobial Agents Journal of Antivirals & Antiretrovirals Journal of Applied & Computational Mathematics Journal of Applied Mechanical Engineering Journal of Applied Pharmacy Journal of Aquaculture Research & Development Journal of Architectural Engineering Technology Journal of Arthritis Journal of Astrobiology & Outreach Journal of Astrophysics & Aerospace Technology Journal of Autacoids and Hormones Journal of Bacteriology & Parasitology Journal of Bioanalysis & Biomedicine Journal of Biochemical and Microbial Toxicology Journal of Biochemistry and Cell Biology Journal of Biodiversity & Endangered Species Journal of Biodiversity, Bioprospecting and Development Journal of Bioengineering & Biomedical Science Journal of Bioengineering and Bioelectronics Journal of Bioequivalence & Bioavailability Journal of Biological and Medical Sciences Journal of Biomedical and Pharmaceutical Sciences Journal of Biomedical Engineering and Medical Devices Journal of Biomedical Systems & Emerging Technologies Journal of Biometrics & Biostatistics Journal of Biomimetics Biomaterials and Tissue Engineering Journal of Biomolecular Research & Therapeutics Journal of Biomusical Engineering Journal of Bioprocessing & Biotechniques Journal of Bioremediation & Biodegradation Journal of Bioresearch Communications Journal of Biosensors & Bioelectronics Journal of Biotechnology & Biomaterials Journal of Bioterrorism & Biodefense Journal of Blood & Lymph Journal of Blood Disorders & Transfusion Journal of Bone Research Journal of Brain Research Journal of Business & Financial Affairs Journal of Cancer Clinical Trials Journal of Cancer Diagnosis Journal of Cancer Research and Immuno-Oncology Journal of Cancer Science & Therapy Journal of Cancer Science and Research Journal of Carcinogenesis & Mutagenesis Journal of Cardiac and Pulmonary Rehabilitation Journal of Cardiovascular Diseases & Diagnosis Journal of Cell Biology & Immunology Journal of Cell Science & Therapy Journal of Cell Science and Apoptosis Journal of Cell Signaling Journal of Cellular and Molecular Pharmacology Journal of Chemical Biology & Therapeutics Journal of Chemical Engineering & Process Technology Journal of Child and Adolescent Behavior Journal of Chromatography & Separation Techniques Journal of Civil & Environmental Engineering Journal of Civil & Legal Sciences Journal of Climatology & Weather Forecasting Journal of Clinical & Cellular Immunology Journal of Clinical & Experimental Cardiology Journal of Clinical & Experimental Dermatology Research Journal of Clinical & Experimental Neuroimmunology Journal of Clinical & Experimental Ophthalmology Journal of Clinical & Experimental Pathology Journal of Clinical & Experimental Pharmacology Journal of Clinical & Medical Genomics Journal of Clinical and Experimental Endocrinology Journal of Clinical and Experimental Transplantation Journal of Clinical and Medical Sciences Journal of Clinical Anesthesiology: Open Access Journal of Clinical Case Reports Journal of Clinical Chemistry and Laboratory Medicine Journal of Clinical Diabetes Journal of Clinical Infectious Diseases & Practice Journal of Clinical Microbiology and Antimicrobials Journal of Clinical Neurology and Neurosurgery Journal of Clinical Research Journal of Clinical Research & Bioethics Journal of Clinical Respiratory Diseases and Care Journal of Clinical Toxicology Journal of Clinical Trials Journal of Coastal Zone Management Journal of Colitis & Diverticulitis Journal of Communication Disorders, Deaf Studies & Hearing Aids Journal of Community & Public Health Nursing Journal of Community Medicine & Health Education Journal of Computer Science & Systems Biology Journal of Congenital Disorders Journal of Coronary Heart Diseases Journal of Cosmetology & Trichology Journal of Cytokine Biology Journal of Cytology & Histology Journal of Data Mining in Genomics & Proteomics Journal of Defense Management Journal of Dementia Journal of Dental Pathology and Medicine Journal of Dental Science and Medicine Journal of Depression and Anxiety Journal of Dermatitis Journal of Developing Drugs Journal of Diabetes & Clinical Practice Journal of Diabetes & Metabolism Journal of Diabetic Complications & Medicine Journal of Down Syndrome & Chromosome Abnormalities Journal of Drug Metabolism & Toxicology Journal of Earth Science & Climatic Change Journal of Ecology and Toxicology Journal of Ecosystem & Ecography Journal of Electrical & Electronic Systems Journal of Entrepreneurship & Organization Management Journal of Environmental & Analytical Toxicology Journal of Environmental Analytical Chemistry Journal of Environmental Hazards Journal of Ergonomics Journal of Experimental Food Chemistry Journal of Eye Diseases and Disorders Journal of Fertilization: In Vitro – IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology Journal of Fisheries & Livestock Production Journal of Food Processing & Technology Journal of Food: Microbiology, Safety & Hygiene Journal of Forensic Biomechanics Journal of Forensic Medicine Journal of Forensic Pathology Journal of Forensic Psychology Journal of Forensic Research Journal of Formulation Science & Bioavailability Journal of Fundamentals of Renewable Energy and Applications Journal of Gastrointestinal & Digestive System Journal of Gastrointestinal Cancer and Stromal Tumors Journal of General Practice Journal of Generalized Lie Theory and Applications Journal of Genetic Syndromes & Gene Therapy Journal of Genetics and DNA Research Journal of Genetics and Genomes Journal of Genome Journal of Geography & Natural Disasters Journal of Geology & Geophysics Journal of Gerontology & Geriatric Research Journal of Global Economics Journal of Glycobiology Journal of Glycomics & Lipidomics Journal of Health & Medical Informatics Journal of Health Care and Prevention Journal of Health Education Research & Development Journal of Hematology & Thromboembolic Diseases Journal of Hepatology and Gastrointestinal disorders Journal of Horticulture Journal of Hotel & Business Management Journal of HPV and Cervical Cancer Journal of Hypertension: Open Access Journal of Immunobiology Journal of Infectious Disease and Pathology Journal of Infectious Diseases & Preventive Medicine Journal of Infectious Diseases & Therapy Journal of Infectious Diseases and Diagnosis Journal of Infectious Diseases and Medicine Journal of Inflammatory Bowel Diseases & Disorders Journal of Information Technology & Software Engineering Journal of Integrative Oncology Journal of Interventional and General Cardiology Journal of Kidney Journal of Lasers, Optics & Photonics Journal of Leukemia Journal of Liver Journal of Lung Cancer Diagnosis & Treatment Journal of Lung Diseases & Treatment Journal of Marine Science: Research & Development Journal of Mass Communication & Journalism Journal of Material Sciences & Engineering Journal of Materials Science and Nanomaterials Journal of Medical & Surgical Pathology Journal of Medical Diagnostic Methods Journal of Medical Implants & Surgery Journal of Medical Microbiology & Diagnosis Journal of Medical Physiology & Therapeutics Journal of Membrane Science & Technology Journal of Meningitis Journal of Mental Disorders and Treatment Journal of Metabolic Syndrome Journal of Microbial & Biochemical Technology Journal of Microbial Pathogenesis Journal of Microbiology and Pathology Journal of Molecular and Genetic Medicine Journal of Molecular Biomarkers & Diagnosis Journal of Molecular Histology & Medical Physiology Journal of Molecular Imaging & Dynamics Journal of Molecular Immunology Journal of Molecular Pathology and Biochemistry Journal of Molecular Pharmaceutics & Organic Process Research Journal of Morphology and Anatomy Journal of Mucosal Immunology Research Journal of Multiple Sclerosis Journal of Nanomedicine & Biotherapeutic Discovery Journal of Nanomedicine & Nanotechnology Journal of Nanosciences: Current Research Journal of Neonatal Biology Journal of Nephrology & Therapeutics Journal of Neuro-Ophthalmology Research Journal of Neuroendocrinology Research Journal of Neuroinfectious Diseases Journal of Neurological Disorders Journal of Neurology & Neurophysiology Journal of Neuroscience and Neuropharmacology Journal of Next Generation Sequencing & Applications Journal of Novel Physiotherapies Journal of Nuclear Medicine & Radiation Therapy Journal of Nursing & Care Journal of Nutrition & Food Sciences Journal of Nutrition & Weight Loss Journal of Nutrition and Dietetics Journal of Nutrition Science Research Journal of Nutritional Disorders & Therapy Journal of Obesity & Weight Loss Therapy Journal of Obesity and Metabolism Journal of Oceanography and Marine Research Journal of Ocular Infection and Inflammation Journal of Odontology Journal of Oncology Medicine & Practice Journal of Oncology Research and Treatment Journal of Oncology Translational Research Journal of Oral Hygiene & Health Journal of Orthopedic Oncology Journal of Osteoporosis and Physical Activity Journal of Paediatric Medicine & Surgery Journal of Pain & Relief Journal of Pain Management & Medicine Journal of Palliative Care & Medicine Journal of Patient Care Journal of Pediatric Neurological Disorders Journal of Pediatric Neurology and Medicine Journal of Perioperative & Critical Intensive Care Nursing Journal of Perioperative Medicine Journal of Petroleum & Environmental Biotechnology Journal of Pharmaceutical Care & Health Systems Journal of Pharmacogenomics & Pharmacoproteomics Journal of Pharmacognosy & Natural Products Journal of Pharmacokinetics & Experimental Therapeutics Journal of Pharmacological Reports Journal of Pharmacovigilance Journal of Phonetics & Audiology Journal of Phylogenetics & Evolutionary Biology Journal of Physical Chemistry & Biophysics Journal of Physical Mathematics Journal of Physiotherapy & Physical Rehabilitation Journal of Phytochemistry & Biochemistry Journal of Pituitary Research & Treatment Journal of Plant Biochemistry & Physiology Journal of Plant Genetics and Breeding Journal of Plant Pathology & Microbiology Journal of Political Sciences & Public Affairs Journal of Pollution Journal of Pollution Effects & Control Journal of Powder Metallurgy & Mining Journal of Pregnancy and Child Health Journal of Probiotics & Health Journal of Prostate Cancer Journal of Proteomics & Bioinformatics Journal of Psychiatry Journal of Psychological Abnormalities Journal of Psychology & Psychotherapy Journal of Pulmonary & Respiratory Medicine Journal of Pulmonology and Respiratory Diseases Journal of Remote Sensing & GIS Journal of Reproductive Biomedicine Journal of Research and Development Journal of Respiratory Medicine Journal of Sleep Disorders & Therapy Journal of Socialomics Journal of Speech Pathology & Therapy Journal of Spine Journal of Sports Medicine & Doping Studies Journal of Steel Structures & Construction Journal of Stem Cell Research & Therapy Journal of Steroids & Hormonal Science Journal of Stock & Forex Trading Journal of Surgery Journal of Surgery and Anesthesia Journal of Surgical Pathology and Diagnosis Journal of Telecommunications System & Management Journal of Textile Science & Engineering Journal of Theoretical & Computational Science Journal of Thermodynamics & Catalysis Journal of Thrombosis and Circulation: Open Access Journal of Thyroid Disorders & Therapy Journal of Tissue Science & Engineering Journal of Tourism & Hospitality Journal of Traditional Medicine & Clinical Naturopathy Journal of Transplantation Technologies & Research Journal of Tropical Diseases & Public Health Journal of Tuberculosis and Therapeutics Journal of Tumor Research Journal of Tumour Research & Reports Journal of Vaccines & Vaccination Journal of Vascular Medicine & Surgery Journal of Vasculitis Journal of Veterinary Medicine and Health Journal of Veterinary Pathology Research Journal of Veterinary Science & Technology Journal of Womens Health Care Journal of Yoga & Physical Therapy Lovotics Lupus: Open Access Malaria Control & Elimination Mass Spectrometry & Purification Techniques Maternal and Pediatric Nutrition Medical & Surgical Urology Medical Reports & Case Studies Medical Safety & Global Health Medicinal & Aromatic Plants Medicinal Chemistry Metabolomics:Open Access Modern Chemistry & Applications Molecular Biology: Open Access Mycobacterial Diseases Natural Products Chemistry & Research Neonatal and Pediatric Medicine Neuroscience and Psychiatry: Open Access Occupational Medicine & Health Affairs Oil & Gas Research OMICS Journal of Radiology Oncology & Cancer Case Reports Optometry: Open Access Oral Health and Dental Management Oral Health Case Reports Organic Chemistry: Current Research Orthopedic & Muscular System: Current Research Otolaryngology: Open Access Pancreatic Disorders & Therapy Pediatric Dental Care Pediatrics & Therapeutics Pharmaceutica Analytica Acta Pharmaceutical Analytical Chemistry: Open Access Pharmaceutical Regulatory Affairs: Open Access Pharmacoeconomics: Open Access Poultry, Fisheries & Wildlife Sciences Primary Healthcare: Open Access Psychology and Psychiatry: Open access Reconstructive Surgery & Anaplastology Reports in Disease Markers Reports in Thyroid Research Reproductive System & Sexual Disorders: Current Research Research and Reports in Medical Sciences Research and reviews on Pathogens Review of Public Administration and Management Rheology: Open Access Rheumatology: Current Research Rice Research: Open Access Single Cell Biology Sociology and Criminology-Open Access Surgery: Current Research The Neurologist: Clinical & Therapeutics Journal The Psychiatrist : Clinical and Therapeutic Journal Toxicology: Open Access Transcriptomics: Open Access Translational Medicine Transplant Reports : Open Access Trauma & Treatment Tropical Medicine & Surgery Virology & Mycology Virology: Current Research Vitamins & Minerals World Journal of Pharmacology and Toxicology

Read more from the original source:
OMICS International | Open Access Journals | Scientific …

Recommendation and review posted by Alexandra Lee Anderson

What is Nanomedicine? : Center for Nanomedicine

Nanomedicine is defined as the medical application of nanotechnology. Nanomedicine can include a wide range of applications, including biosensors, tissue engineering, diagnostic devices, and many others. In the Center for Nanomedicine at Johns Hopkins, we focus on harnessing nanotechnology to more effectively diagnose, treat, and prevent various diseases. Our entire bodies are exposed to the medicines that we take, which can lead to unpleasant side effects and minimize the amount of medicine that reaches the places where it is needed. Medications can be more efficiently delivered to the site of action using nanotechnology, resulting in improved outcomes with less medication.

For example, treating cancer with current chemotherapy delivery techniques is like spraying an entire rose garden with poison in order to kill a single weed. It would be far more effective to spray a small amount of poison, directly on the weed, and save the roses. In this analogy, a cancer patients hair follicles, immune cells, and epithelia are the roses being poisoned by the chemotherapy. Using nanotechnology, we can direct the chemotherapy to the tumor and minimize exposure to the rest of the body. In addition, our nanotechnologies are more capable of bypassing internal barriers (see Technologies), further improving upon conventional nanotechnologies. Not only is our approach more effective at eradicating tumors (see Cancer under Research), but it also results in much higher quality of life for the patient.

Nanotechnology can also reduce the frequency with which we have to take our medications. Typically, the human body can very quickly and effectively remove medications, reducing the duration of action. For example, the current treatment for age-related macular degeneration (AMD) requires monthly injections into the eye in a clinical setting. However, if the medication is slowly released from the inside of a nanoparticle, the frequency of injection can be reduced to once every 6 months (see Eye under Research). The nanoparticle itself also slowly biodegrades into components that naturally occur in the body, which are also removed from the body after the medication has done its job. This exciting technology is currently being commercialized and moved toward clinical trials (see Commercialization).

Nanomedicine will lead to many more exciting medical breakthroughs. Please explore our various nanotechnology platforms and the numerous areas in which we are pursuing nanomedicine-based medical solutions.

See the original post here:
What is Nanomedicine? : Center for Nanomedicine

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine | medicine |

Nanomedicine, branch of medicine that seeks to apply nanotechnologythat is, the manipulation and manufacture of materials and devices that are smaller than 1 nanometre [0.0000001 cm] in sizeto the prevention of disease and to imaging, diagnosis, monitoring, treatment, repair, and regeneration of biological systems.

Although nanomedicine remains in its early stages, a number of nanomedical applications have been developed. Research thus far has focused on the development of biosensors to aid in diagnostics and vehicles to administer vaccines, medications, and genetic therapy, including the development of nanocapsules to aid in cancer treatment.

An offshoot of nanotechnology, nanomedicine is an emerging field and had garnered interest as a site for global research and development, which gives the field academic and commercial legitimacy. Funding for nanomedicine research comes both from public and private sources, and the leading investors are the United States, the United Kingdom, Germany, and Japan. In terms of the volume of nanomedicine research, these countries are joined by China, France, India, Brazil, Russia, and India.

Working at the molecular-size scale, nanomedicine is animated with promises of the seamless integration of biology and technology, the eradication of disease through personalized medicine, targeted drug delivery, regenerative medicine, as well as nanomachinery that can substitute portions of cells. Although many of these visions may not come to fruition, some nanomedicine applications have become reality, with the potential to radically transform the practice of medicine, as well as current understandings of the health, disease, and biologyissues that are of vital importance for contemporary societies. The fields global market share totalled some $78 billion dollars in 2012, driven by technological advancements. By the end of the decade, the market is expected to grow to nearly $200 billion.

Nanomedicine derives much of its rhetorical, technological, and scientific strength from the scale on which it operates (1 to 100 nanometers), the size of molecules and biochemical functions. The term nanomedicine emerged in 1999, the year when American scientist Robert A. Freitas Jr. published Nanomedicine: Basic Capabilities, the first of two volumes he dedicated to the subject.

Extending American scientist K. Eric Drexlers vision of molecular assemblers with respect to nanotechnology, nanomedicine was depicted as facilitating the creation of nanobot devices (nanoscale-sized automatons) that would navigate the human body searching for and clearing disease. Although much of this compelling imagery still remains unrealized, it underscores the underlying vision of doctors being able to search and destroy diseased cells, or of nanomachines that substitute biological parts, which still drives portrayals of the field. Such illustrations remain integral to the field, being used by scientists, funding agencies, and the media alike.

Attesting to the fields actuality are numerous dedicated scientific and industry-oriented conferences, peer-reviewed scientific journals, professional societies, and a growing number of companies. However, nanomedicines identity, scope, and goals are a matter of controversy. In 2006, for instance, the prestigious journal Nature Materials discussed the ongoing struggle of policy makers to understand if nanomedicine is a rhetorical issue or a solution to a real problem. This ambivalence is reflected in the numerous definitions of nanomedicine that can be found in scientific literature, that range from complicated drugs to the above mentioned nanobots. Despite the lack of a shared definition, there is a general agreement that nanomedicine entails the application of nanotechnology in medicine and that it will profoundly impact medical practice.

A further topic of debate is nanomedicines genealogy, in particular its connections to molecular medicine and nanotechnology. The case of nanotechnology is exemplary: on one hand, its potentialin terms of science but also in regard to funding and recognitionis often mobilized by nanomedicine proponents; on the other, there is an attempt to distance nanomedicine from nanotechnology, for fear of being damaged by the perceived hype that surrounds it. The push is then for nanomedicine to emerge not as a subdiscipline of nanotechnology but as a parallel field.

Although nanomedicine research and development is actively pursued in numerous countries, the United States, the EU (particularly Germany), and Japan have made significant contributions from the fields outset. This is reflected both in the number of articles published and in that of patents filed, both of which have grown exponentially since 2004. By 2012, however, nanomedicine research in China grew with respect to publications in the field, and the country ranked second only to the United States in the number of research articles published.

In 2004, two U.S. funding agenciesthe National Institutes of Health and the National Cancer Instituteidentified nanomedicine as a priority research area allocating $144 million and $80 million, respectively, to its study. In the EU meanwhile, public granting institutions did not formally recognize nanomedicine as a field, providing instead funding for research that falls under the headers of nanotechnology and health. Such lack of coordination had been the target of critiques by the European Science Foundation (ESF), warning that it would result in lost medical benefits. In spite of this, the EU ranked first in number of nanomedicine articles published and in 2007 the Seventh Framework Programme (FP7) allocated 250 million to nanomedicine research. Such work has also been heavily funded by the private sector. A study led by the European Science and Technology Observatory found that over 200 European companies were researching and developing nanomedicine applications, many of which were coordinating their efforts.

Much of nanomedicine research is application oriented, emphasizing methods to transfer it from the laboratory to the bedside. In 2005 the ESF pointed to four main subfields in nanomedicine research: analytical tools and nanoimaging, nanomaterials and nanodevices, novel therapeutics and drug delivery systems, and clinical, regulatory, and toxicological issues. Research in analytical tools and nanoimaging seeks to develop noninvasive, reliable, cheap, and highly sensitive tools for in vivo diagnosis and visualization. The ultimate goal is to create fully functional mobile sensors that can be remotely controlled to conduct in vivo, real-time analysis. Research on nanomaterials and nanodevices aims to improve the biocompatibility and mechanical properties of biomaterials used in medicine, so as to create safer implants, substitute damaged cell parts, or stimulate cell growth for tissue engineering and regeneration, to name a few. Work in novel therapeutics and drug delivery systems strives to develop and design nanoparticles and nanostructures that are noninvasive and can target specific diseases, as well as cross biological barriers. Allied with very precise means for diagnosis, these drug delivery systems would enable equally precise site-specific therapeutics and fewer side effects. The area of drug delivery accounts for a large portion of nanomedicines scientific publications.

Finally, the subfield of clinical, regulatory, and toxicological issues lumps together research that examines the field as a whole. Questions of safety and toxicology are prevalent, an issue that is all the more important given that nanomedicine entails introducing newly engineered nanoscale particles, materials, and devices into the human body. Regulatory issues revolve around the management of this newness, with some defending the need for new regulation, and others the ability of systems to deal with it. This subfield should also include other research by social scientists and humanists, namely on the ethics of nanomedicine.

Combined, these subfields build a case for preventive medicine and personalized medicine. Building upon genomics, personalized medicine envisions the possibility of individually tailored diagnostics and therapeutics. Preventive medicine takes this notion further, conjuring the possibility of treating a disease before it manifests itself. If realized, such shifts would have radical impacts on understandings of health, embodiment, and personhood. Questions remain concerning the cost and accessibility of nanomedicine and also about the consequences of diagnostics based on risk propensity or that lack a cure.

Read more from the original source:
Nanomedicine | medicine |

Recommendation and review posted by Alexandra Lee Anderson

EUNCL | Nanomedicine Characterisation Laboratory

European Nanomedicine Characterisation Laboratory

Our Mission is to provide a trans-disciplinary testing infrastructure covering a comprehensive set of preclinical characterisation assays (physical, chemical, in-vitro and in-vivo biological testing) allowing researchers to fully comprehend the bio distribution, metabolism, pharmacokinetics, safety profiles and immunological effects of their Med-NPs.

We are fostering the use and deployment of standard operating procedures (SOPs), benchmark materials, and quality management for the preclinical characterisation of Med-NPs (nanoparticles used for medical applications).

As nanomedicine is a fast evolving field of research, it is a key objective for EUNCL to constantly refine and adapt its assay portfolio and processes in order maintain the provision of state-of-the-art TNA to the scientific community. Therefore, we will progressively implement additional assays to increase our characterisation capacity, for instance in terms of medical application or route of administration.

The emphasis of the EUNCL is to serve as a nexus for trans-disciplinary research, development and clinical applications of nanotechnology. Therefore, lessons-learned, best practices, knowledge, tools and methods will be made available to the scientific community such as academic researchers, industry, regulatory bodies, metrology institutes and others. However, care will be taken to ensure that proprietary information and materials disclosed to the EUNCL by the TNA users are protected.

Follow this link:
EUNCL | Nanomedicine Characterisation Laboratory

Recommendation and review posted by Alexandra Lee Anderson

Regenerative Nanomedicine Lab –

Our recent research article “In-vitro Topographical Model of Fuchs Dystrophy for Evaluation of Corneal Endothelial Cell Monolayer Formation” appeared on theBack cover of Advanced Healthcare Materials latest issue.

Several diseases have been known to be caused by microstructural changes in the extracellular microenvironment. Therefore, the knowledge of the interaction of cells with the altered extracellular micro-structures or surface topography is critical to develop a better understanding of the disease for therapeutic development. One such disease is Fuchs corneal endothelial dystrophy (FED). FED is the primary disease and major reason of corneal endothelial cell death. If left untreated, corneal blindness will be resulted; thus, FED is the leading indication for corneal transplantation. In the USA, 4% of population over the age of 40 is believed to have compromised corneal endothelium due to FED, which will further increase due to increasing life expectancy and rapidly ageing population. A diagnostic clinical hallmark of FED is the development of discrete pillar or dome-like microstructures on the corneal endothelial basement membrane (Descemet membrane). These microstructures are called corneal guttata or guttae. Cell therapies have been proposed as an alternative treatment method for Fuchs dystrophy patients. However, currently, no in-vitro or in-vivo FED disease model is available to study the cell therapies before clinical trials.

In this study, the pathological changes in the micro-structure of basement membranes resulting from FED disease was analyzed, to identify geometrical dimension to develop an in-vitro disease model of synthetic corneal guttata pillars/domes by using microfabrication techniques. This model was used to study the monolayer formation of donor-derived human corneal endothelial cells to test the effectiveness of the corneal endothelial cell regenerative therapies. The results suggest that the corneal cell therapies may not be equally effective for patients at different stages of disease progression. The pre-existing guttata in patients could interfere with the cells thus hampering monolayer formation within the eye. Surgical removal of the guttata from the diseased Descemet membrane prior to cell regenerative therapy could increase the success rate of monolayer formation, which could potentially increase the chances of cell therapy success. This study also demonstrate how biomaterial design can be employed to mimic the pathological microstructural changes in basement membranes for better understanding of cellular responses in disease conditions.

The rest is here:
Regenerative Nanomedicine Lab –

Recommendation and review posted by Alexandra Lee Anderson

Top Nanomedicine Conferences|DrugDelivery meetings …

About Us

International Conference and Exhibition on Nanomedicine and Drug Delivery May 21-23, 2018 Tokyo, Japan

ConferenceSeries Ltdis a renowned organization that organizes highly notablePharmaceutical Conferencesthroughout the globe. Currently we are bringing forth2ndInternational Conference on Nanomedicine and Drug Delivery(NanoDelivery 2018) scheduled to be held duringMay 21-23, 2018 at Tokyo, Japan. The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.

For More PS:

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine, Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedical applications, Nanomaterials for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical, Industry and Market processing and drug delivery promise to transform the world of Advanced nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drug delivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2018 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from todays industry leaders.

The Nanodelivery 2018 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Who’s Coming to Nanodelivery 2018?

The field ofNano Deliverynow has pivotal roles in electronics, biology and medicine. Its application can be appraised, as it involves the materials to be designed at atomic and molecular level. Due to the advantage of their size, nanospheres have been shown to be robustdrug delivery systemsand may be useful for encapsulating drugs and enabling more precise targeting with a controlled release. In this review specifically, we highlight the recent advances of this technology for medicine and drug delivery systems. Nanomaterialsrange from 10200 nm up to a few micrometres in size, and include nano- and microparticles, nanotubes and quantum dots.

Nanotechnological devices are made from metals, polymers, lipids and organic substances as well as from macromolecules such as dendrimers, antibodies, micelles, liposomes and nanofibers. Nanomedicine makes use of these nanostructures for diagnostic or therapeutic applications in all fields of medicine, using them for drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions, where “cell repair machines” could revolutionize medicine and the medical field. Asdrug delivery systems,nanoparticlescan be designed to improve the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter thepharmacokineticsand biodistribution of drugs.

ConferenceSeries Ltdorganizes aconference seriesof 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 morescientificsocietiesand publishes 700+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1:Advanced Nanomedicine

Advanced Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

26th International Conference on Advanced Nanotechnology October 04-05 2018 Moscow, Russia; 18th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care September 05-06, 2018 Auckland, Newzealand;International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology, April 09-11, 2018 Amsterdam, Netherlands; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017

Track 2:Design of Nanodrugs

To reach target cell, designing of nanodrugs are major aspects, where researcher interested for developing novel Nanodrugs.

Aimed and specially designed session for researchers developing Nanodrugs for delivery ofamino acids,Nucleic acidsand proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano Drugs, Nanodrugs for Cancer Therapy, Nanodrugs for Veterinary Therapeutics, Nanodrugs for Medical applications and Nanodrugs forHerbal medicinesand Cosmetics.

Related conferences:

14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 4th International Conference and Expo on Drug Discovery, Designing & Development September 06-07, 2018 London, UK; International Conference on Biomedicine & Pharmacotherapy August 06-07, 2018 Osaka, Japan; 16th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Track 3:Nanomedicine and Nanotechnology

Nanotechnology for canceris a field that incorporates the studies related to nanosized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope ofnanotechnologytowards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug andadvances in nanotechnology.

Nanotechnologyis an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.

The session Design of Nanomedicine and Nanotechnology includes broad topics like: Carbon Nanotubes,Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nanobioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.

Related conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 4:Synthesis of Nanoparticles for Drug Delivery

Nanoparticles(NPs) have wide range of applications in areas such as health care, cosmetics, food and feed, environmental health, mechanics, optics, biomedical sciences, chemical industries, electronics, space industries, drug-gene delivery, energy science, optoelectronics, catalysis, single electron transistors, light emitters, nonlinear optical devices, and photo-electrochemical applications.

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such asliposomesare used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle

Nanocarriers, Gold Nanoparticles, Silver Nanoparticles, Liposomes, ligands,Nanoemulsions, Solid Lipid Nanoparticles, Polymeric Nanoparticles, Dendrimer Nanocarriers, Silica materials and Carbon Nanocarriers,nanotechnology and medicine.

Related conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 5:Regenerative Medicine and Tissue Engineering

The promise of regenerative medicine is truly remarkable.Regenerative medicineis a new branch of medicine that attempts to change the course of chronic disease, in many instances regenerating failing organ systems lost due to age, disease, damage, or congenital defects. The area is rapidly becoming one of the most promising treatment options for patients suffering from tissue failure.

TissueEngineering and Regenerative Medicine is appealing to scientists, physicians, and lay people alike: to heal tissue or organ defects that the current medical practice deems difficult or impossible to cure.

It covers numerous topics, such as stem cells, cell culture, polymer synthesis, novelbiomaterials, drug delivery, therapeutics, and the creation of tissues and organs.

This session dedicated to helping provide research-based solutions to issues related to human diseases and include with sessions as: tissue engineering, Organ fabrication, Tissue printing, Biomaterials, Biologic scaffolds, Hydrogels, Cell seeded matrices, Bioreactor design, Mechanical conditioning of engineered tissues, Mechanical properties of engineered tissues, Physiological properties of engineered tissues, Clinical outcomes of engineered tissue implantation, Cell-based therapies.

Related conferences:

Tissue Engineering and Regenerative Medicine ConferenceAug 20-22, 2017 Baltimore, USA;Stem Cell And Regenerative Medicine MeetingsMarch 20-22, 2017 Berlin, Germany; 8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 5th InternationalConference onCell and Gene TherapyMay 19-21, 2016 San Antonio, USA; InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA;Conference on Cardiac Development, Regeneration and RepairApril 3 7, 2016 Snowbird, Utah, USA; TheConference onStem Cell Development,May 22-26, 2016 Hillerd, Denmark;Conference onHematopoietic Stem Cells: June 3-5, 2016 Heidelberg, Germany;ISSCR Pluripotency ConferenceMarch 22-24, 2016 Kyoto, Japan ,Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT),American Association for the Advancement of Science , Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 6:Nanomedicine in Theranostics

Theranosticnanomedicineis emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them bothimagingand therapeutic functions. The resulting nanosystems, capable of diagnosis,drug deliveryand monitoring oftherapeuticresponse, are expected to play a significant role in the dawning era ofpersonalized medicine, and much research effort has been devoted toward that goal.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 7:Nanomedicines and Biomedical Applications

Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 8:Drug Delivery Research

Drug Delivery Conferences attains greater global significance asDrug Deliveryplays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics likelipid Polymersto enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs.In vitro & in vivodissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latestTargeted drug deliveryis a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.Pharmacokineticbehavior indrug designanddrug developmentfor safety issues arising either as a result of animal toxicity testing or in the clinical program itself

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 9:Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developingdrug delivery systemsvia Novel techniques forPharmaceutical formulationdevelopment, Drug Delivery conference themed quality topics onLiposomes, Dendrimer,Targeted Drug Deliverydesign, versatile polymer in Drug Delivery andControlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, SustainedDrug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development andPharmacology.

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 10:Smart Drug Delivery Technology

To maximize knowledge of the current researcher on developingdrug deliveryviaPharmaceutical formulation, Smart Drug Delivery conference themed quality topics onDrug Targeting,Drug Designing,Drug evaluation,Drug Delivery and Therapeutics, Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 11:Nano Pharmaceuticals

Pharmaceutical NanotechnologyforDrug Delivery using Nanotechnologysession plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology,anticancer drug development,pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestinglypharmaceutical sciencesare usingnanoparticlesto reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Nano technology session includesdrug delivery using nanotechnology,Pharmaceutical technology, Nanoparticles permeability to BBB,Cancer drug targets, Nanoparticles application,Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this reviewPolymer Nanotechnologyfor Drug Delivery,Nano compositematerials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

Related Conferences:

20thInternationalConference on Nanoscience, Dec 19-20, 2017 Osaka, Japan 11thInternationalConference on Molecular Nanotechnology, October 20-22, 2016 Rome, Italy, UK; InternationalConference on Nano medicine, July 24-25, 2017 Melbourne, Australia;Conference on Nanotechnologyin Health Care , July 24-25, 2017 Melbourne, Australia; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 12:Biopharmaceutics and Biologic Drugs

Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products. The process of movement of drug from its site of administration to the systemic circulation is called as absorption. The concentration of drug in plasma and hence the onset of action, and the intensity and duration of response depend upon the bioavailability of drug from its dosage form. Bioavailability is defined as the rate and extent (amount) of drug absorption.Biologic Drugs, or biologic response modifiers, are medications genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease. Biologics target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory arthritis. Biologic response modifiers (biologics for short) are drugs that are genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease.

Related conference:

13th International Conference on Biopharma and BiotherapeuticsOctober 24-25, 2018 Boston, Massachusetts, USA ,Global Summit on Biopharma and BiotherapeuticsMontreal, Canada May 14-15, 2018,International Conference on Nano Medicine and NanoparticlesApril 18-19, 2018 Las Vegas, USA11th European Biosimilars CongressApril 26-27, 2018 Rome, Italy

Track 13:Nano Biotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology.Nanobiotechnologyhas multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 14:Nano Pharmaceutical Industry and Market

Nano Pharmaceutical IndustryCompanies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co,biopharmaceutical Manufacturing and Industries, generic drugscompanies,contract drug delivery companieswhich can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of theClinical bio therapeuticsthemselves. This session includes Rheological behavior,Pharmaceutical Guidelines,Pharmaceutical companies and regulatory guidelinesperspectives, Advances in computational modeling forbioavailability,drug Stabilityof Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Related Conferences:

International Conference onPharma Marketing Conference, November 17-19, 2016 Alicante, Spain; 4th Annual conferences onEuropean Pharma Congress, June 13-15, 2016 Berlin, Germany; 2ndInternationalConference on Biologic Drugs, September 15-17, 2016 San Antonio, USA; 3rdWorldCongress on PharmacologyAugust 08-10, 2016 Birmingham, UK; 2ndInternationalConference on Parenterals, December 05-07, 2016 Dallas, Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016 Dallas, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 15:Regulatory Aspects Towards Approval of Nanomedicine

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Summary of Nanodelivery 2018 Conference:

Nano Delivery 2018is an emerging field of engineering andlife sciencesthat promises to revolutionizemedicineand medical technology. There are numerous applications ofnanomedicineandDrug Delivery using Nanotechnologyin medicinal diagnostics. These include improvedimaginingof the human (or any) body and detectingtumorsthat are only a few cells in size.

The idea thatpharmaceutical agentsshould be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient.Targeted drug-deliveryallows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.

Nanomedicine hastherapeuticuses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms orcancer cellsby interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.

The global market forhealthcare nanotechnologyis expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Importance & Scope of Nano Delivery:

Read the original post:
Top Nanomedicine Conferences|DrugDelivery meetings …

Recommendation and review posted by Alexandra Lee Anderson

Journal of Nanomedicine & Nanotechnology – Open Access Journals

NLM ID : 101562615SJR H Index:13, Google Scholar h5-index: 13ICDS = 3.8ICV Value: 101.22

Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.

Journal of Nanomedicine & Nanotechnology covers wide varieties of topics such as molecular nanotechnology, nanosensors, nanoparticles, nanodrugs, Nanomaterials, nanobiotechnology, nanobiopharmaceutics, nanoelectronics, nanorobotics, etc.. The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

The journal is using Editorial Manager System for quality peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Nanomedicine & Nanotechnology or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

The Journal of Nanomedicine & Nanotechnology is a scientific journal which provides an opportunity to share the information among the medical scientists and researchers. The main function of open access publishing platforms is to present the content online, making it available to all, and link this information with useful scientific data.The Journal of Nanomedicine & Nanotechnology aims to publish articles bimonthly and is one of the best open access journals of scholarly publishing.

Journal of Nanomedicine & Nanotechnology is anacademic journal which aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of Research articles, Review articles, Case reports, Short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

You can find a clear view of peer review process by clicking here.

Material Science Research: Material Science and NanotechnoMaterials are crucial to the performance and reliability of virtually every technology and the vitality and health of any living organism. The central theme of materials science and engineering is that the process by which a material comes into being determines its structure, which in turn controls its properties and ultimately its functional performance.

Nanotechnology is the engineering of functional systems at the molecular scale. It is the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

Related Journals of NanotechnologyNanoscience and Nanotechnology, Nanoscience and Nanotechnology Letters, Journal of Nanomedicine & Biotherapeutic Discovery, IEEE Transactions on Nanobioscience, Journal of Biomedical Nanotechnology, Photonics and Nanostructures – Fundamentals and Applications

Nanobiotechnology is the application of nanotechnology to the life sciences: The technology encompasses precision engineering as well as electronics, and electromechanical systems as well as mainstream biomedical applications in areas as diverse as gene therapy, drug delivery and novel drug discovery techniques.

Related Journals of NanobiotechnologyJournal of Biomedical Nanotechnology, Research Journal of Nanoscience and nanotechnology, Nature Nanotechnology Journal, Nanomaterials & Molecular Nanotechnology, Nature Nanotechnology, Nano Letters, Advanced Materials, Nano Today

A Nanocomposite is a multiphase solid material where one of the phases has one, two or three dimensions of less than 100nm, or structure having nano-scale repeat distance between the different phases that make up the material.

Related Journals of Nanocomposites

Journal of Nanomaterial and Nanotechnology, International Journal of Nanotechnology Impact Factor, Journal of Nanomedicine & Biotherapeutic Discovery, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology, Materials Science & Engineering A: Structural Materials: Properties, Microstructure and Processing

The Integrated Project Nanobiopharmaceutics aims at the development of innovative multidisciplinary approaches for the design, synthesis and evaluation of functionalised nano-carriers and nano-particle-based micro-carriers for the treatment of various diseases based on targeted, controlled delivery of therapeutic peptides and proteins (biopharmaceutics).

Related Journals of NanobiopharmaceuticsJournal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanobiomedical Impact Factor, Journal of Obsessive-Compulsive and Related Disorders, Journal of Homotopy and Related Structures, Journal of Venomous Animals and Toxins including Tropical Diseases

Nanoelectronics is one of the major technologies of Nanotechnology. It plays vital role in the field of engineering and electronics.

Related Journals of Nanoelectronics Journal of Nanotechnology and Electrophysics, Nano Research & Applications, ACS Applied Materials and Interfaces, International Journal of Nanotechnology Applications, Biosensors and Bioelectronics, Journal of Physical Chemistry C, Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology.

Related Journals of Nanomedicine Nanomaterials & Molecular Nanotechnology, Pharmaceutical Nanotechnology, Journal of Biomedical Nanotechnology, International Journal of Nanomedicine, Nanomedicine: Nanotechnology, Biology and Medicine, Journal of Nanomedicine Research, European Journal of Nanomedicine

Nanotoxicology is a branch of toxicology concerned with the study of the toxicity of nanomaterials, which can be divided into those derived from combustion processes (like diesel soot), manufacturing processes (such as spray drying or grinding) and naturally occurring processes (such as volcanic eruptions or atmospheric reactions).

Related Journals of NanotoxicologyNanomedicine & Nanotechnology, Nanotechnology Journal Lists, Nano Journal Impact Factor, Microscale Thermophysical Engineering, Microelectronic Engineering, Nano Biomedicine and Engineering, Nano-Micro Letters

Nanoengineering is the practice of engineering on the nanoscale. It derives its name from the nanometre, a unit of measurement equalling one billionth of a meter. Nanoengineering is largely a synonym for nanotechnology, but emphasizes the engineering rather than the pure science aspects of the field.

Related Journals of NanoengineeringJournal of Nanoresearch, Review in Nanoscience and Nanotechnology, Nature Nanotechnology Journal, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Nanotoxicology, Precision Engineering, Nanomedicine, Nanotechnology

The spontaneous association of molecules under equilibrium conditions into stable, structurally well-defined aggregates.

Related Journals of NanofabricationsJournal of Nanotechnology Impact Factor, Nanotechnology Journal Lists, Journal of Nano, Nanomaterials & Molecular Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine, Beilstein Journal of Nanotechnology

Nanofluidics is often defined as the study and application of fluid flow in and around nanosized objects.

Related Journals of Nanofluidics Research Journal of Nanoscience and Nanotechnology, Nano Journal Impact Factor, Journal of Nanotechnology and Electrophysics, Journal of Bionanoscience, Nanotechnology, Science and Applications, Journal of Nanobiotechnology, Plasmonics, Biomedical Microdevices

Nanohedron aims to exhibit scientific images, with a focus on images depicting nanoscale objects. The work ranges from electron microscopy images of nanoscale materials to graphical renderings of molecules. Scientific images lying outside the realm of nanoscience such as algorithmic art or confocal microscopy images of cells will also be considered.

Related Journals of Nanohedron Biomicrofluidics, Nanotechnology Journal Lists, Nano Journal Impact Factor, IEEE Transactions on Nanotechnology, Microfluidics and Nanofluidics, Journal of Micromechanics and Microengineering

Nano Cars Into the robotics is new technology which is useful for designing robots. Difference in exisiting robotics and nano cars is this system works as nervous system where as in existing system stepper motors are used.

Related Journals of Nanocars Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Review in Nanoscience and Nanotechnology,Nanomedicine & Biotherapeutic Discovery, ACS Nano, Advanced Functional Materials, Journal of Physical Chemistry Letters, Biomaterials, Small, Nano Research

Nanothermite, as the name suggests, is thermite in which the particles are so small that they are measured in nanometers is an ultra-fine-grained (UFG) variant of thermite that can be formulated to be explosive by adding gas-releasing substances.

Related Journals of NanothermiteNanoscale Research Letters, Journal of Nanobiomedical Impact Factor, International Journal of Nanoscience, Microelectronics and Reliability, Journal of Nanoparticle Research, AIP Advances

A sequence of nanoscale C60 atoms arranged in a long thin cylindrical structure. Nanotubes are extremely strong mechanically and very pure conductors of electric current. Applications of the nanotube in nanotechnology include resistors, capacitors, inductors, diodes and transistors.

Related Journals of NanotubesNanotechnology journals, Nature Nanotechnology Journal, Nano Journal Impact Factor, ACM Journal on Emerging Technologies in Computing Systems, Science of Advanced Materials, Journal of Nanophotonics

Having an organization more complex than that of a molecule.

Realated Journals of Supramolecule Plasmonics, Journal of Biomedical Nanotechnology, International Journal of Nanoscience, Journal of Nanobiomedical Impact Factor, Biomedical Microdevices, Biomicrofluidics, IEEE Transactions on Nanotechnology

Nanoionics is the study and application of phenomena, properties, effects and mechanisms of processes connected with fast ion transport (FIT) in all-solid-state nanoscale systems.

Related Journals of Nanoionics Journal of Nanoresearch, Journal of Nanoscience and Nanotechnology, Journal of Biomedical Nanotechnology, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine

Nanolithography is the branch of nanotechnology concerned with the study and application of fabricating nanometer-scale structures, meaning patterns with at least one lateral dimension between 1 and 100 nm.

Related Journals of NanolithographyInternational Journal of Nanotechnology, Journal of Nanotechnology Impact Factor, Nanoscience and Nanotechnology Letters, Nano Research, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology

Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties. Particles are further classified according to diameter.

Related Journals of Nanoparticles Journal of Nanoscience and Nanotechnology, International Journal of Nanoscience, Journal of Nanomaterial and Nanotechnology, Journal of Nanoparticle Research, Journal of Nanoparticles, International Journal of Nanoparticles,

Exploitation of biomaterials, devices or methodologies on the nanoscale.

Related Journals of Bionanoscience Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Journal of Biomedical Nanotechnology, Recent Patents in Nanotechnology, Journal of Bionanoscience, BioNanoScience, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials

Read the original post:
Journal of Nanomedicine & Nanotechnology – Open Access Journals

Recommendation and review posted by Alexandra Lee Anderson